0001179110-17-006795.txt : 20170508
0001179110-17-006795.hdr.sgml : 20170508
20170508145538
ACCESSION NUMBER: 0001179110-17-006795
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170504
FILED AS OF DATE: 20170508
DATE AS OF CHANGE: 20170508
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
DATE OF NAME CHANGE: 20121107
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROPER WILLIAM L
CENTRAL INDEX KEY: 0001087960
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 17821828
MAIL ADDRESS:
STREET 1: 21250 HAWTHORNE BLVD
STREET 2: SUITE 800
CITY: TORRANCE
STATE: CA
ZIP: 90503
4
1
edgar.xml
FORM 4 -
X0306
4
2017-05-04
0
0000927066
DAVITA INC.
DVA
0001087960
ROPER WILLIAM L
C/O DAVITA INC.
2000 16TH STREET
DENVER
CO
80202
1
0
0
0
Common Stock
2017-05-04
4
M
0
36000
42.465
A
45277
D
Common Stock
2017-05-04
4
F
0
23006
66.45
D
22271
D
Common Stock
2017-05-04
4
S
0
12994
65.8879
D
9277
D
Stock Appreciation Rights
42.465
2017-05-04
4
M
0
36000
42.465
A
2013-06-11
2017-06-11
Common Stock
36000
0
D
Represents the weighted average sale price of $65.8879. The range of prices for the sale of these shares was $65.6600 - $66.2800 rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The Stock Appreciation Rights were granted on 6/11/2012, and vested 100% on 6/11/2013.
/s/ Arturo Sida, Attorney-in-Fact
2017-05-08